Testosterone and Female Libido: What Does the Evidence Say?

Do Women Naturally Have Testosterone?

Yes.

Testosterone is not exclusively a male hormone.

Women naturally produce androgens, including testosterone, and these hormones are involved in several aspects of physiology.

Testosterone can act directly through androgen receptors and can also be converted within tissues into other hormones.

But the fact that women naturally produce testosterone does not mean every change in libido can be reduced to a testosterone deficiency.

Women have testosterone. Female sexual desire is still far more complicated than a testosterone number.

Sexual desire reflects interactions between:

• brain reward and motivation;
• hormones;
• physical health;
• sleep;
• stress;
• mood;
• medication;
• body image;
• sexual pleasure;
• pain or vaginal discomfort;
• relationship context;
• previous sexual experiences.

Does Testosterone Control Female Libido?

It influences sexual function, but “controls” is too simple.

The relationship between naturally occurring testosterone levels and sexual desire in women is surprisingly difficult to define.

International consensus guidance notes that the association between circulating androgen concentrations and female sexual function remains uncertain.

That means two women with similar testosterone levels can experience very different levels of sexual desire.

And a woman can experience distressingly low sexual desire without having an unusually low testosterone blood result.

Can a Testosterone Blood Test Explain Low Libido in Women?

Not by itself.

This is one of the most important points in the evidence.

There is no established testosterone cutoff that separates women with healthy sexual desire from women with HSDD.

A blood test therefore cannot be used like this:

Your testosterone is below X, therefore that is why you do not want sex.

Nor does a result within a laboratory reference range prove that hormones are irrelevant.

When testosterone treatment is being considered, clinicians may measure total testosterone primarily to establish a baseline and help prevent treatment from producing levels outside the normal physiological female range.

What Does the Evidence Say About Testosterone for Female Libido?

The evidence is strongest for a relatively specific group.

International consensus guidance concluded that the clearest evidence-based indication for testosterone therapy in women is:

postmenopausal women with HSDD after appropriate biopsychosocial assessment.

Studies using doses designed to keep testosterone within physiological female ranges have shown improvements in areas including:

• sexual desire;
• sexual responsiveness;
• arousal;
• pleasure;
• orgasmic function;
• sexual distress.

The effect is real but should not be described as dramatic or universal.

Some women benefit.

Some do not.

The evidence supports testosterone as a targeted treatment for selected women with distressing low desire — not as a universal libido booster.

What Is HSDD?

HSDD stands for hypoactive sexual desire disorder.

It refers to persistently low sexual desire associated with meaningful personal distress.

The distress component matters.

A woman who rarely wants sex but is completely comfortable with her level of desire does not automatically have a disorder.

Likewise, a temporarily lower libido during:

• severe stress;
• sleep deprivation;
• illness;
• relationship conflict;
• bereavement;
• postpartum recovery;
• a medication change;

should not automatically be converted into an HSDD diagnosis.

A proper assessment looks at the wider sexual and life context.

Why the Biopsychosocial Assessment Matters

Before treating low desire with testosterone, guidelines emphasise looking for other contributors.

If one of those factors is doing most of the work, adding testosterone may not address the real problem.

What About Testosterone for Low Libido During Perimenopause?

This is where the evidence becomes less certain.

The strongest international evidence is in postmenopausal women.

The 2019 Global Consensus Position Statement concluded that evidence was insufficient to make recommendations for testosterone treatment of sexual function in premenopausal women.

Later sexual-medicine guidance has noted limited evidence in some women in the late reproductive years, but this remains a more specialised clinical decision.

That matters because perimenopause can begin while periods are still occurring.

Low libido during perimenopause may also be driven by:

• poor sleep;
• night sweats;
• anxiety;
• vaginal dryness;
• pain;
• relationship stress;
• medication;
• changing arousal patterns.

See Perimenopause and Low Libido: Why Desire Can Change.

Is the Evidence Stronger After Menopause?

Yes.

This is where randomised controlled trials and international consensus are most supportive.

For postmenopausal women with properly assessed HSDD, physiological-dose testosterone can produce a moderate improvement in sexual function compared with placebo.

The Global Consensus Position Statement reported improvements across sexual desire and several related domains.

But the recommendation does not mean:

Every postmenopausal woman with less sex drive should take testosterone.

It applies to women experiencing persistent low desire associated with distress after the wider causes have been evaluated.

Does HRT Usually Come Before Testosterone?

For menopause-associated symptoms, often yes.

NICE advises considering testosterone supplementation for low sexual desire associated with menopause when HRT alone has not been effective.

This does not mean every woman must take HRT before testosterone in every possible clinical situation.

It reflects the need to first consider whether estrogen-related menopause symptoms are contributing.

For example, HRT may improve:

• hot flushes;
• night sweats;
• sleep disruption;
• some genitourinary symptoms;
• other menopause-associated symptoms.

If those problems were suppressing sexual interest, sexual wellbeing may improve without testosterone being necessary.

Sometimes the route back to desire is not directly increasing desire. It is treating the symptoms that made sex difficult to want.

What Benefits Can Testosterone Have for Women With HSDD?

In appropriately selected postmenopausal women, research has found improvements in several aspects of sexual function.

The benefit is generally described as moderate.

It is not a treatment that makes every woman suddenly highly sexual.

How Quickly Does Testosterone Work for Female Libido?

It is not an instant-effect treatment.

Clinical guidance typically treats testosterone as a monitored therapeutic trial rather than something judged after a few days.

If treatment is appropriate, the clinician watches for meaningful improvement over time.

If there is no meaningful benefit after an adequate trial, continuing indefinitely is generally not recommended.

What Are the Risks and Side Effects of Testosterone in Women?

When testosterone is prescribed at physiological female doses, short-term trial data are relatively reassuring.

But side effects can occur.

Possible androgen-related effects include:

• acne;
• increased facial or body hair;
• scalp hair changes in susceptible women;
• other signs of excessive androgen exposure if doses are too high.

Preparations that produce testosterone levels far above the normal female range are not recommended.

The major uncertainty is long-term safety.

International guidance notes that longer-term cardiovascular and breast safety data remain limited.

What Form of Testosterone Is Used for Female Low Libido?

The evidence and guidelines favour transdermal testosterone given in doses intended to maintain levels within the physiological female range.

Transdermal means testosterone absorbed through the skin, typically as a gel or cream.

In many countries, a testosterone product specifically licensed for women is not available.

Clinicians may therefore prescribe a carefully reduced amount of a product originally formulated for men, depending on local regulations and clinical guidance.

International consensus guidance advises against formulations that can generate excessively high testosterone levels.

Compounded products also raise concerns about dose consistency and evidence unless no appropriate authorised alternative exists and strict quality standards are followed.

Why Does Testosterone Treatment Need Monitoring?

Monitoring is not about proving that your testosterone was “too low.”

It is largely about keeping treatment within a safe physiological range and checking whether it is actually helping.

A clinician may:

• take a sexual and medical history;
• review menopause symptoms;
• review medication;
• consider relationship and psychological contributors;
• measure baseline total testosterone;
• sometimes measure sex hormone-binding globulin;
• repeat blood testing after treatment begins;
• check for acne, unwanted hair growth, or other androgen effects;
• review whether desire and sexual distress are actually improving.

The target is not:

the highest testosterone level that makes me feel sexual.

The target is treatment within the normal physiological female range while assessing clinical benefit.

The blood test helps monitor testosterone treatment. It does not tell the clinician how much desire a woman should have.

Can Testosterone Be Used for Energy, Brain Fog, Mood, or General Wellbeing?

This is where marketing often runs ahead of evidence.

The international consensus statement does not support testosterone as a general treatment for:

• improving overall wellbeing;
• treating depressed mood;
• improving cognition;
• preventing cognitive decline;
• general anti-ageing purposes.

The evidence-based sexual-health indication is much narrower.

What Else Can Cause Low Libido in Women?

Before testosterone becomes the answer, it is worth understanding the wider possibilities.

For the broader overview, see Low Libido in Women: Why Sexual Desire Can Change.

What if You Love Your Partner but Still Have No Sexual Desire?

This is precisely why a hormone-only explanation can be misleading.

You can:

love your partner;

feel emotionally safe;

find them attractive;

enjoy affection;

and still have very little spontaneous sexual desire.

That may involve:

• menopause;
• medication;
• sleep;
• stress;
• physical discomfort;
• responsive rather than spontaneous desire;
• or HSDD.

It may also involve several of them together.

See Why Do I Love My Partner but Not Want Sex?.

Could It Be Responsive Desire Rather Than a Hormone Problem?

Sometimes.

A woman may interpret the disappearance of spontaneous sexual thoughts as evidence that her libido is broken.

But some women experience sexual desire more responsively.

They do not necessarily feel a strong urge before intimacy begins.

Instead, wanted affection or erotic stimulation creates arousal, and desire develops from there.

This does not explain every case of low libido.

But it is important to understand before deciding that a lack of spontaneous desire must require hormone treatment.

See What Is Responsive Desire?.

How Should You Talk to a Doctor About Testosterone and Libido?

Instead of asking only:

Can you check whether my testosterone is low?

give the clinician the sexual history.

Explain:

• what your desire used to be like;
• when it changed;
• whether the change is persistent;
• whether it causes distress;
• whether you still experience attraction;
• whether masturbation or fantasy has changed;
• whether sex is painful or dry;
• whether arousal or orgasm has changed;
• whether you are perimenopausal or postmenopausal;
• whether you use HRT;
• which medicines you take;
• what your sleep and mood are like;
• whether relationship stress or sexual pressure is involved.

Do Testosterone Supplements or “Female Hormone Boosters” Work?

Be careful with this category.

Prescription testosterone therapy studied for HSDD is not the same thing as an over-the-counter product marketed as a testosterone booster.

Supplements may:

• contain ingredients with limited evidence;
• use doses that have not been tested for HSDD;
• interact with medication;
• make hormone claims that exceed the evidence;
• avoid the monitoring used with prescription hormone therapy.

A supplement labelled:

female testosterone support

does not mean it has been shown to treat clinically significant low sexual desire.

For the broader commercial evidence boundary, see Female Libido Supplements: What to Know Before Buying.

Testosterone Is One Tool, Not a Diagnosis

The evidence around testosterone and female libido is more useful when both extremes are avoided.

It is not true that testosterone has no role in female sexual desire.

There is meaningful evidence that physiological-dose therapy can help selected women with HSDD, particularly after menopause.

But it is equally misleading to say:

Low sex drive in women means low testosterone.

The science does not support that shortcut.

Testosterone can be an evidence-based treatment for selected women with distressing low desire. It is not a blood-test explanation for every woman who wants sex less often than she used to.

This article is part of the Sexual Intimacy and Desire in Relationships: Complete Guide.

For menopause specifically, see Menopause, Low Libido and Relationship Intimacy.

For perimenopause, see Perimenopause and Low Libido: Why Desire Can Change.

For the core cluster question, see Why Have I Lost Interest in Sex With My Partner?.

And if the libido change is persistent or unexplained, see When a Change in Sexual Desire May Need Medical Support.

FAQ: Testosterone and Female Libido